nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A4—Temozolomide—brain cancer	0.121	0.387	CbGbCtD
Vardenafil—CYP3A4—Lomustine—brain cancer	0.103	0.329	CbGbCtD
Vardenafil—CYP3A5—Etoposide—brain cancer	0.0639	0.204	CbGbCtD
Vardenafil—PDE6H—pineal body—brain cancer	0.0411	0.201	CbGeAlD
Vardenafil—CYP3A4—Etoposide—brain cancer	0.0249	0.0796	CbGbCtD
Vardenafil—PDE10A—ganglion—brain cancer	0.0192	0.0937	CbGeAlD
Vardenafil—PDE5A—endothelium—brain cancer	0.00967	0.0473	CbGeAlD
Vardenafil—PDE5A—blood vessel—brain cancer	0.00892	0.0436	CbGeAlD
Vardenafil—Sildenafil—CYP2C9—brain cancer	0.00883	1	CrCbGaD
Vardenafil—PDE10A—telencephalon—brain cancer	0.00739	0.0361	CbGeAlD
Vardenafil—PDE1B—telencephalon—brain cancer	0.00733	0.0358	CbGeAlD
Vardenafil—PDE11A—endocrine gland—brain cancer	0.00717	0.0351	CbGeAlD
Vardenafil—PDE6H—endocrine gland—brain cancer	0.00717	0.0351	CbGeAlD
Vardenafil—PDE6H—head—brain cancer	0.00708	0.0346	CbGeAlD
Vardenafil—PDE6G—head—brain cancer	0.00681	0.0333	CbGeAlD
Vardenafil—PDE6H—central nervous system—brain cancer	0.00646	0.0316	CbGeAlD
Vardenafil—PDE1B—gonad—brain cancer	0.00611	0.0299	CbGeAlD
Vardenafil—PDE6H—brain—brain cancer	0.00513	0.0251	CbGeAlD
Vardenafil—PDE11A—brain—brain cancer	0.00513	0.0251	CbGeAlD
Vardenafil—PDE1B—endocrine gland—brain cancer	0.00462	0.0226	CbGeAlD
Vardenafil—PDE10A—head—brain cancer	0.0046	0.0225	CbGeAlD
Vardenafil—PDE1B—head—brain cancer	0.00456	0.0223	CbGeAlD
Vardenafil—PDE5A—telencephalon—brain cancer	0.00433	0.0211	CbGeAlD
Vardenafil—PDE10A—central nervous system—brain cancer	0.0042	0.0205	CbGeAlD
Vardenafil—PDE1B—central nervous system—brain cancer	0.00416	0.0204	CbGeAlD
Vardenafil—PDE10A—cerebellum—brain cancer	0.00411	0.0201	CbGeAlD
Vardenafil—PDE1B—cerebellum—brain cancer	0.00407	0.0199	CbGeAlD
Vardenafil—PDE5A—gonad—brain cancer	0.00361	0.0177	CbGeAlD
Vardenafil—PDE10A—brain—brain cancer	0.00334	0.0163	CbGeAlD
Vardenafil—PDE1B—brain—brain cancer	0.00331	0.0162	CbGeAlD
Vardenafil—PDE5A—endocrine gland—brain cancer	0.00273	0.0133	CbGeAlD
Vardenafil—PDE5A—head—brain cancer	0.00269	0.0132	CbGeAlD
Vardenafil—PDE5A—central nervous system—brain cancer	0.00246	0.012	CbGeAlD
Vardenafil—PDE5A—cerebellum—brain cancer	0.0024	0.0117	CbGeAlD
Vardenafil—Hepatic enzyme increased—Temozolomide—brain cancer	0.00236	0.00752	CcSEcCtD
Vardenafil—Infection—Carboplatin—brain cancer	0.00236	0.00751	CcSEcCtD
Vardenafil—Neck pain—Carmustine—brain cancer	0.00234	0.00745	CcSEcCtD
Vardenafil—Dysphagia—Procarbazine—brain cancer	0.00232	0.00738	CcSEcCtD
Vardenafil—Angina pectoris—Procarbazine—brain cancer	0.00226	0.00719	CcSEcCtD
Vardenafil—Influenza like illness—Temozolomide—brain cancer	0.00217	0.00691	CcSEcCtD
Vardenafil—Photosensitivity reaction—Procarbazine—brain cancer	0.00211	0.00674	CcSEcCtD
Vardenafil—Infection—Lomustine—brain cancer	0.00206	0.00657	CcSEcCtD
Vardenafil—Cardiovascular disorder—Etoposide—brain cancer	0.00203	0.00648	CcSEcCtD
Vardenafil—Pain—Carboplatin—brain cancer	0.00203	0.00646	CcSEcCtD
Vardenafil—Abnormal vision—Carmustine—brain cancer	0.00201	0.00642	CcSEcCtD
Vardenafil—Face oedema—Hydroxyurea—brain cancer	0.002	0.00638	CcSEcCtD
Vardenafil—Sweating—Procarbazine—brain cancer	0.00198	0.00631	CcSEcCtD
Vardenafil—Haematuria—Procarbazine—brain cancer	0.00197	0.00628	CcSEcCtD
Vardenafil—PDE5A—brain—brain cancer	0.00195	0.00954	CbGeAlD
Vardenafil—Epistaxis—Procarbazine—brain cancer	0.00195	0.00621	CcSEcCtD
Vardenafil—Abnormal vision—Temozolomide—brain cancer	0.00195	0.00621	CcSEcCtD
Vardenafil—Blood creatinine increased—Hydroxyurea—brain cancer	0.00194	0.00619	CcSEcCtD
Vardenafil—Breast disorder—Hydroxyurea—brain cancer	0.00187	0.00598	CcSEcCtD
Vardenafil—Haemoglobin—Procarbazine—brain cancer	0.00186	0.00594	CcSEcCtD
Vardenafil—Eye pain—Carmustine—brain cancer	0.00186	0.00592	CcSEcCtD
Vardenafil—Haemorrhage—Procarbazine—brain cancer	0.00185	0.00591	CcSEcCtD
Vardenafil—Injury—Carmustine—brain cancer	0.00182	0.00582	CcSEcCtD
Vardenafil—Eye pain—Temozolomide—brain cancer	0.0018	0.00572	CcSEcCtD
Vardenafil—Amnesia—Carmustine—brain cancer	0.00178	0.00569	CcSEcCtD
Vardenafil—Nasal congestion—Temozolomide—brain cancer	0.00178	0.00567	CcSEcCtD
Vardenafil—Hot flush—Temozolomide—brain cancer	0.00173	0.00552	CcSEcCtD
Vardenafil—Amnesia—Temozolomide—brain cancer	0.00172	0.0055	CcSEcCtD
Vardenafil—Flushing—Procarbazine—brain cancer	0.00172	0.00549	CcSEcCtD
Vardenafil—Menopausal symptoms—Temozolomide—brain cancer	0.00172	0.00547	CcSEcCtD
Vardenafil—Oesophagitis—Etoposide—brain cancer	0.00163	0.0052	CcSEcCtD
Vardenafil—Face oedema—Carmustine—brain cancer	0.00162	0.00516	CcSEcCtD
Vardenafil—Infestation—Hydroxyurea—brain cancer	0.0016	0.0051	CcSEcCtD
Vardenafil—Infestation NOS—Hydroxyurea—brain cancer	0.0016	0.0051	CcSEcCtD
Vardenafil—Face oedema—Temozolomide—brain cancer	0.00156	0.00499	CcSEcCtD
Vardenafil—Liver function test abnormal—Carmustine—brain cancer	0.00155	0.00493	CcSEcCtD
Vardenafil—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00151	0.00482	CcSEcCtD
Vardenafil—Breast disorder—Temozolomide—brain cancer	0.00146	0.00467	CcSEcCtD
Vardenafil—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00146	0.00465	CcSEcCtD
Vardenafil—Dysphagia—Carmustine—brain cancer	0.00145	0.00462	CcSEcCtD
Vardenafil—Syncope—Procarbazine—brain cancer	0.00145	0.00461	CcSEcCtD
Vardenafil—Haemoglobin—Hydroxyurea—brain cancer	0.00144	0.0046	CcSEcCtD
Vardenafil—Haemorrhage—Hydroxyurea—brain cancer	0.00144	0.00457	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00143	0.00456	CcSEcCtD
Vardenafil—Loss of consciousness—Procarbazine—brain cancer	0.00142	0.00452	CcSEcCtD
Vardenafil—Dysphagia—Temozolomide—brain cancer	0.0014	0.00446	CcSEcCtD
Vardenafil—Convulsion—Procarbazine—brain cancer	0.0014	0.00446	CcSEcCtD
Vardenafil—Arthralgia—Procarbazine—brain cancer	0.00137	0.00438	CcSEcCtD
Vardenafil—Myalgia—Procarbazine—brain cancer	0.00137	0.00438	CcSEcCtD
Vardenafil—Anxiety—Procarbazine—brain cancer	0.00137	0.00437	CcSEcCtD
Vardenafil—Dry mouth—Procarbazine—brain cancer	0.00134	0.00428	CcSEcCtD
Vardenafil—Vomiting—Lomustine—brain cancer	0.00132	0.00421	CcSEcCtD
Vardenafil—Infection—Procarbazine—brain cancer	0.00131	0.00417	CcSEcCtD
Vardenafil—Angiopathy—Hydroxyurea—brain cancer	0.0013	0.00415	CcSEcCtD
Vardenafil—Shock—Procarbazine—brain cancer	0.0013	0.00413	CcSEcCtD
Vardenafil—Tachycardia—Procarbazine—brain cancer	0.00129	0.0041	CcSEcCtD
Vardenafil—Photosensitivity reaction—Temozolomide—brain cancer	0.00128	0.00408	CcSEcCtD
Vardenafil—Hyperhidrosis—Procarbazine—brain cancer	0.00127	0.00406	CcSEcCtD
Vardenafil—Erythema—Hydroxyurea—brain cancer	0.00125	0.00398	CcSEcCtD
Vardenafil—Infestation NOS—Temozolomide—brain cancer	0.00125	0.00398	CcSEcCtD
Vardenafil—Infestation—Temozolomide—brain cancer	0.00125	0.00398	CcSEcCtD
Vardenafil—Nausea—Lomustine—brain cancer	0.00123	0.00393	CcSEcCtD
Vardenafil—Hypotension—Procarbazine—brain cancer	0.00123	0.00392	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Procarbazine—brain cancer	0.0012	0.00383	CcSEcCtD
Vardenafil—Insomnia—Procarbazine—brain cancer	0.00119	0.0038	CcSEcCtD
Vardenafil—Paraesthesia—Procarbazine—brain cancer	0.00118	0.00377	CcSEcCtD
Vardenafil—Hepatobiliary disease—Temozolomide—brain cancer	0.00118	0.00376	CcSEcCtD
Vardenafil—Sinusitis—Temozolomide—brain cancer	0.00117	0.00373	CcSEcCtD
Vardenafil—Somnolence—Procarbazine—brain cancer	0.00117	0.00373	CcSEcCtD
Vardenafil—Cramp muscle—Etoposide—brain cancer	0.00117	0.00372	CcSEcCtD
Vardenafil—Haemoglobin—Carmustine—brain cancer	0.00117	0.00372	CcSEcCtD
Vardenafil—Haemorrhage—Carmustine—brain cancer	0.00116	0.0037	CcSEcCtD
Vardenafil—Ill-defined disorder—Hydroxyurea—brain cancer	0.00116	0.00369	CcSEcCtD
Vardenafil—Hypoaesthesia—Carmustine—brain cancer	0.00115	0.00368	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Etoposide—brain cancer	0.00114	0.00365	CcSEcCtD
Vardenafil—Connective tissue disorder—Carmustine—brain cancer	0.00114	0.00363	CcSEcCtD
Vardenafil—CYP3A5—endocrine gland—brain cancer	0.00113	0.00554	CbGeAlD
Vardenafil—Haemoglobin—Temozolomide—brain cancer	0.00113	0.00359	CcSEcCtD
Vardenafil—Malaise—Hydroxyurea—brain cancer	0.00113	0.00359	CcSEcCtD
Vardenafil—Pain—Procarbazine—brain cancer	0.00113	0.00359	CcSEcCtD
Vardenafil—Haemorrhage—Temozolomide—brain cancer	0.00112	0.00357	CcSEcCtD
Vardenafil—Dysphagia—Etoposide—brain cancer	0.00112	0.00357	CcSEcCtD
Vardenafil—Visual impairment—Carmustine—brain cancer	0.00112	0.00356	CcSEcCtD
Vardenafil—Hypoaesthesia—Temozolomide—brain cancer	0.00112	0.00356	CcSEcCtD
Vardenafil—Pharyngitis—Temozolomide—brain cancer	0.00111	0.00355	CcSEcCtD
Vardenafil—Urinary tract disorder—Temozolomide—brain cancer	0.00111	0.00353	CcSEcCtD
Vardenafil—Connective tissue disorder—Temozolomide—brain cancer	0.0011	0.00351	CcSEcCtD
Vardenafil—Urethral disorder—Temozolomide—brain cancer	0.0011	0.0035	CcSEcCtD
Vardenafil—Feeling abnormal—Procarbazine—brain cancer	0.00109	0.00346	CcSEcCtD
Vardenafil—Eye disorder—Carmustine—brain cancer	0.00108	0.00346	CcSEcCtD
Vardenafil—Convulsion—Hydroxyurea—brain cancer	0.00108	0.00345	CcSEcCtD
Vardenafil—Visual impairment—Temozolomide—brain cancer	0.00108	0.00344	CcSEcCtD
Vardenafil—Gastrointestinal pain—Procarbazine—brain cancer	0.00108	0.00343	CcSEcCtD
Vardenafil—Flushing—Carmustine—brain cancer	0.00108	0.00343	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00106	0.00337	CcSEcCtD
Vardenafil—Discomfort—Hydroxyurea—brain cancer	0.00105	0.00335	CcSEcCtD
Vardenafil—Eye disorder—Temozolomide—brain cancer	0.00105	0.00334	CcSEcCtD
Vardenafil—Tinnitus—Temozolomide—brain cancer	0.00105	0.00333	CcSEcCtD
Vardenafil—Abdominal pain—Procarbazine—brain cancer	0.00104	0.00332	CcSEcCtD
Vardenafil—Flushing—Temozolomide—brain cancer	0.00104	0.00332	CcSEcCtD
Vardenafil—Cardiac disorder—Temozolomide—brain cancer	0.00104	0.00332	CcSEcCtD
Vardenafil—Angiopathy—Temozolomide—brain cancer	0.00102	0.00324	CcSEcCtD
Vardenafil—Mental disorder—Carmustine—brain cancer	0.00102	0.00324	CcSEcCtD
Vardenafil—Infection—Hydroxyurea—brain cancer	0.00101	0.00323	CcSEcCtD
Vardenafil—Immune system disorder—Temozolomide—brain cancer	0.00101	0.00323	CcSEcCtD
Vardenafil—Mediastinal disorder—Temozolomide—brain cancer	0.00101	0.00322	CcSEcCtD
Vardenafil—Erythema—Carmustine—brain cancer	0.00101	0.00322	CcSEcCtD
Vardenafil—Nervous system disorder—Hydroxyurea—brain cancer	0.001	0.00319	CcSEcCtD
Vardenafil—Infestation NOS—Etoposide—brain cancer	0.000999	0.00319	CcSEcCtD
Vardenafil—Infestation—Etoposide—brain cancer	0.000999	0.00319	CcSEcCtD
Vardenafil—Skin disorder—Hydroxyurea—brain cancer	0.00099	0.00316	CcSEcCtD
Vardenafil—Acute coronary syndrome—Etoposide—brain cancer	0.000985	0.00314	CcSEcCtD
Vardenafil—Mental disorder—Temozolomide—brain cancer	0.000982	0.00313	CcSEcCtD
Vardenafil—Myocardial infarction—Etoposide—brain cancer	0.00098	0.00312	CcSEcCtD
Vardenafil—Back pain—Carmustine—brain cancer	0.000977	0.00311	CcSEcCtD
Vardenafil—Erythema—Temozolomide—brain cancer	0.000976	0.00311	CcSEcCtD
Vardenafil—Hypersensitivity—Procarbazine—brain cancer	0.000971	0.00309	CcSEcCtD
Vardenafil—Vision blurred—Carmustine—brain cancer	0.000952	0.00303	CcSEcCtD
Vardenafil—Asthenia—Procarbazine—brain cancer	0.000945	0.00301	CcSEcCtD
Vardenafil—Hepatobiliary disease—Etoposide—brain cancer	0.000945	0.00301	CcSEcCtD
Vardenafil—Back pain—Temozolomide—brain cancer	0.000944	0.00301	CcSEcCtD
Vardenafil—Pruritus—Procarbazine—brain cancer	0.000932	0.00297	CcSEcCtD
Vardenafil—Vision blurred—Temozolomide—brain cancer	0.00092	0.00293	CcSEcCtD
Vardenafil—Dyspnoea—Hydroxyurea—brain cancer	0.000909	0.0029	CcSEcCtD
Vardenafil—Somnolence—Hydroxyurea—brain cancer	0.000906	0.00289	CcSEcCtD
Vardenafil—Ill-defined disorder—Temozolomide—brain cancer	0.000906	0.00289	CcSEcCtD
Vardenafil—Diarrhoea—Procarbazine—brain cancer	0.000901	0.00287	CcSEcCtD
Vardenafil—Dyspepsia—Hydroxyurea—brain cancer	0.000897	0.00286	CcSEcCtD
Vardenafil—Hypoaesthesia—Etoposide—brain cancer	0.000893	0.00285	CcSEcCtD
Vardenafil—Angioedema—Temozolomide—brain cancer	0.000892	0.00284	CcSEcCtD
Vardenafil—Urinary tract disorder—Etoposide—brain cancer	0.000886	0.00282	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00088	0.00281	CcSEcCtD
Vardenafil—Malaise—Temozolomide—brain cancer	0.00088	0.00281	CcSEcCtD
Vardenafil—Urethral disorder—Etoposide—brain cancer	0.000879	0.0028	CcSEcCtD
Vardenafil—Vertigo—Temozolomide—brain cancer	0.000877	0.00279	CcSEcCtD
Vardenafil—Convulsion—Carmustine—brain cancer	0.000875	0.00279	CcSEcCtD
Vardenafil—Pain—Hydroxyurea—brain cancer	0.000872	0.00278	CcSEcCtD
Vardenafil—Dizziness—Procarbazine—brain cancer	0.000871	0.00278	CcSEcCtD
Vardenafil—Palpitations—Temozolomide—brain cancer	0.000862	0.00275	CcSEcCtD
Vardenafil—Chest pain—Carmustine—brain cancer	0.00086	0.00274	CcSEcCtD
Vardenafil—Myalgia—Carmustine—brain cancer	0.00086	0.00274	CcSEcCtD
Vardenafil—Anxiety—Carmustine—brain cancer	0.000857	0.00273	CcSEcCtD
Vardenafil—CYP3A4—endocrine gland—brain cancer	0.00085	0.00416	CbGeAlD
Vardenafil—Convulsion—Temozolomide—brain cancer	0.000846	0.0027	CcSEcCtD
Vardenafil—Feeling abnormal—Hydroxyurea—brain cancer	0.00084	0.00268	CcSEcCtD
Vardenafil—Eye disorder—Etoposide—brain cancer	0.000838	0.00267	CcSEcCtD
Vardenafil—Vomiting—Procarbazine—brain cancer	0.000838	0.00267	CcSEcCtD
Vardenafil—Flushing—Etoposide—brain cancer	0.000833	0.00265	CcSEcCtD
Vardenafil—Cardiac disorder—Etoposide—brain cancer	0.000833	0.00265	CcSEcCtD
Vardenafil—Myalgia—Temozolomide—brain cancer	0.000831	0.00265	CcSEcCtD
Vardenafil—Arthralgia—Temozolomide—brain cancer	0.000831	0.00265	CcSEcCtD
Vardenafil—Rash—Procarbazine—brain cancer	0.000831	0.00265	CcSEcCtD
Vardenafil—Dermatitis—Procarbazine—brain cancer	0.00083	0.00265	CcSEcCtD
Vardenafil—Anxiety—Temozolomide—brain cancer	0.000828	0.00264	CcSEcCtD
Vardenafil—Headache—Procarbazine—brain cancer	0.000825	0.00263	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000825	0.00263	CcSEcCtD
Vardenafil—Discomfort—Temozolomide—brain cancer	0.000821	0.00262	CcSEcCtD
Vardenafil—Infection—Carmustine—brain cancer	0.000819	0.00261	CcSEcCtD
Vardenafil—Angiopathy—Etoposide—brain cancer	0.000814	0.00259	CcSEcCtD
Vardenafil—Dry mouth—Temozolomide—brain cancer	0.000813	0.00259	CcSEcCtD
Vardenafil—Immune system disorder—Etoposide—brain cancer	0.00081	0.00258	CcSEcCtD
Vardenafil—Mediastinal disorder—Etoposide—brain cancer	0.000809	0.00258	CcSEcCtD
Vardenafil—Tachycardia—Carmustine—brain cancer	0.000804	0.00256	CcSEcCtD
Vardenafil—Anaphylactic shock—Temozolomide—brain cancer	0.000796	0.00254	CcSEcCtD
Vardenafil—Infection—Temozolomide—brain cancer	0.000791	0.00252	CcSEcCtD
Vardenafil—Nausea—Procarbazine—brain cancer	0.000783	0.00249	CcSEcCtD
Vardenafil—Nervous system disorder—Temozolomide—brain cancer	0.000781	0.00249	CcSEcCtD
Vardenafil—Skin disorder—Temozolomide—brain cancer	0.000774	0.00247	CcSEcCtD
Vardenafil—Hypotension—Carmustine—brain cancer	0.00077	0.00245	CcSEcCtD
Vardenafil—Hyperhidrosis—Temozolomide—brain cancer	0.00077	0.00245	CcSEcCtD
Vardenafil—CYP3A4—central nervous system—brain cancer	0.000766	0.00375	CbGeAlD
Vardenafil—Back pain—Etoposide—brain cancer	0.000755	0.00241	CcSEcCtD
Vardenafil—Hypersensitivity—Hydroxyurea—brain cancer	0.000751	0.00239	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Carmustine—brain cancer	0.000751	0.00239	CcSEcCtD
Vardenafil—Muscle spasms—Etoposide—brain cancer	0.000751	0.00239	CcSEcCtD
Vardenafil—Insomnia—Carmustine—brain cancer	0.000745	0.00238	CcSEcCtD
Vardenafil—Paraesthesia—Carmustine—brain cancer	0.00074	0.00236	CcSEcCtD
Vardenafil—Dyspnoea—Carmustine—brain cancer	0.000735	0.00234	CcSEcCtD
Vardenafil—Somnolence—Carmustine—brain cancer	0.000733	0.00234	CcSEcCtD
Vardenafil—Asthenia—Hydroxyurea—brain cancer	0.000732	0.00233	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000726	0.00231	CcSEcCtD
Vardenafil—Ill-defined disorder—Etoposide—brain cancer	0.000725	0.00231	CcSEcCtD
Vardenafil—Insomnia—Temozolomide—brain cancer	0.00072	0.0023	CcSEcCtD
Vardenafil—Paraesthesia—Temozolomide—brain cancer	0.000715	0.00228	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Carmustine—brain cancer	0.000712	0.00227	CcSEcCtD
Vardenafil—Dyspnoea—Temozolomide—brain cancer	0.00071	0.00226	CcSEcCtD
Vardenafil—Somnolence—Temozolomide—brain cancer	0.000708	0.00226	CcSEcCtD
Vardenafil—Pain—Carmustine—brain cancer	0.000705	0.00225	CcSEcCtD
Vardenafil—Malaise—Etoposide—brain cancer	0.000704	0.00224	CcSEcCtD
Vardenafil—Vertigo—Etoposide—brain cancer	0.000702	0.00224	CcSEcCtD
Vardenafil—Dyspepsia—Temozolomide—brain cancer	0.000701	0.00223	CcSEcCtD
Vardenafil—Diarrhoea—Hydroxyurea—brain cancer	0.000698	0.00222	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Temozolomide—brain cancer	0.000688	0.00219	CcSEcCtD
Vardenafil—Loss of consciousness—Etoposide—brain cancer	0.000686	0.00219	CcSEcCtD
Vardenafil—Pain—Temozolomide—brain cancer	0.000681	0.00217	CcSEcCtD
Vardenafil—Feeling abnormal—Carmustine—brain cancer	0.000679	0.00216	CcSEcCtD
Vardenafil—Convulsion—Etoposide—brain cancer	0.000677	0.00216	CcSEcCtD
Vardenafil—Dizziness—Hydroxyurea—brain cancer	0.000674	0.00215	CcSEcCtD
Vardenafil—Gastrointestinal pain—Carmustine—brain cancer	0.000674	0.00215	CcSEcCtD
Vardenafil—Chest pain—Etoposide—brain cancer	0.000665	0.00212	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00066	0.0021	CcSEcCtD
Vardenafil—Discomfort—Etoposide—brain cancer	0.000657	0.00209	CcSEcCtD
Vardenafil—Feeling abnormal—Temozolomide—brain cancer	0.000656	0.00209	CcSEcCtD
Vardenafil—Abdominal pain—Carmustine—brain cancer	0.000652	0.00208	CcSEcCtD
Vardenafil—Gastrointestinal pain—Temozolomide—brain cancer	0.000651	0.00208	CcSEcCtD
Vardenafil—Vomiting—Hydroxyurea—brain cancer	0.000648	0.00207	CcSEcCtD
Vardenafil—Rash—Hydroxyurea—brain cancer	0.000643	0.00205	CcSEcCtD
Vardenafil—Dermatitis—Hydroxyurea—brain cancer	0.000642	0.00205	CcSEcCtD
Vardenafil—Headache—Hydroxyurea—brain cancer	0.000639	0.00204	CcSEcCtD
Vardenafil—Anaphylactic shock—Etoposide—brain cancer	0.000637	0.00203	CcSEcCtD
Vardenafil—Infection—Etoposide—brain cancer	0.000633	0.00202	CcSEcCtD
Vardenafil—Abdominal pain—Temozolomide—brain cancer	0.00063	0.00201	CcSEcCtD
Vardenafil—Tachycardia—Etoposide—brain cancer	0.000622	0.00198	CcSEcCtD
Vardenafil—Skin disorder—Etoposide—brain cancer	0.000619	0.00197	CcSEcCtD
Vardenafil—Hyperhidrosis—Etoposide—brain cancer	0.000616	0.00196	CcSEcCtD
Vardenafil—Hypersensitivity—Carmustine—brain cancer	0.000607	0.00194	CcSEcCtD
Vardenafil—Nausea—Hydroxyurea—brain cancer	0.000606	0.00193	CcSEcCtD
Vardenafil—Hypotension—Etoposide—brain cancer	0.000596	0.0019	CcSEcCtD
Vardenafil—Asthenia—Carmustine—brain cancer	0.000591	0.00188	CcSEcCtD
Vardenafil—Hypersensitivity—Temozolomide—brain cancer	0.000587	0.00187	CcSEcCtD
Vardenafil—Paraesthesia—Etoposide—brain cancer	0.000572	0.00182	CcSEcCtD
Vardenafil—Asthenia—Temozolomide—brain cancer	0.000571	0.00182	CcSEcCtD
Vardenafil—Dyspnoea—Etoposide—brain cancer	0.000568	0.00181	CcSEcCtD
Vardenafil—Somnolence—Etoposide—brain cancer	0.000567	0.00181	CcSEcCtD
Vardenafil—Diarrhoea—Carmustine—brain cancer	0.000564	0.0018	CcSEcCtD
Vardenafil—Pruritus—Temozolomide—brain cancer	0.000564	0.0018	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Etoposide—brain cancer	0.00055	0.00175	CcSEcCtD
Vardenafil—Dizziness—Carmustine—brain cancer	0.000545	0.00174	CcSEcCtD
Vardenafil—Pain—Etoposide—brain cancer	0.000545	0.00174	CcSEcCtD
Vardenafil—Diarrhoea—Temozolomide—brain cancer	0.000545	0.00174	CcSEcCtD
Vardenafil—Dizziness—Temozolomide—brain cancer	0.000527	0.00168	CcSEcCtD
Vardenafil—Feeling abnormal—Etoposide—brain cancer	0.000525	0.00167	CcSEcCtD
Vardenafil—Vomiting—Carmustine—brain cancer	0.000524	0.00167	CcSEcCtD
Vardenafil—Gastrointestinal pain—Etoposide—brain cancer	0.000521	0.00166	CcSEcCtD
Vardenafil—Rash—Carmustine—brain cancer	0.00052	0.00166	CcSEcCtD
Vardenafil—Dermatitis—Carmustine—brain cancer	0.000519	0.00165	CcSEcCtD
Vardenafil—Headache—Carmustine—brain cancer	0.000516	0.00165	CcSEcCtD
Vardenafil—Vomiting—Temozolomide—brain cancer	0.000506	0.00161	CcSEcCtD
Vardenafil—Abdominal pain—Etoposide—brain cancer	0.000504	0.00161	CcSEcCtD
Vardenafil—Rash—Temozolomide—brain cancer	0.000502	0.0016	CcSEcCtD
Vardenafil—Dermatitis—Temozolomide—brain cancer	0.000502	0.0016	CcSEcCtD
Vardenafil—Headache—Temozolomide—brain cancer	0.000499	0.00159	CcSEcCtD
Vardenafil—Nausea—Carmustine—brain cancer	0.00049	0.00156	CcSEcCtD
Vardenafil—Nausea—Temozolomide—brain cancer	0.000473	0.00151	CcSEcCtD
Vardenafil—Hypersensitivity—Etoposide—brain cancer	0.00047	0.0015	CcSEcCtD
Vardenafil—Asthenia—Etoposide—brain cancer	0.000457	0.00146	CcSEcCtD
Vardenafil—Pruritus—Etoposide—brain cancer	0.000451	0.00144	CcSEcCtD
Vardenafil—Diarrhoea—Etoposide—brain cancer	0.000436	0.00139	CcSEcCtD
Vardenafil—Dizziness—Etoposide—brain cancer	0.000421	0.00134	CcSEcCtD
Vardenafil—Vomiting—Etoposide—brain cancer	0.000405	0.00129	CcSEcCtD
Vardenafil—Rash—Etoposide—brain cancer	0.000402	0.00128	CcSEcCtD
Vardenafil—Dermatitis—Etoposide—brain cancer	0.000401	0.00128	CcSEcCtD
Vardenafil—Headache—Etoposide—brain cancer	0.000399	0.00127	CcSEcCtD
Vardenafil—Nausea—Etoposide—brain cancer	0.000379	0.00121	CcSEcCtD
Vardenafil—PDE6G—Signaling Pathways—GLI2—brain cancer	0.000368	0.0023	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SUFU—brain cancer	0.000358	0.00224	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—GLI2—brain cancer	0.000358	0.00224	CbGpPWpGaD
Vardenafil—PDE6G—Disease—ENO2—brain cancer	0.000357	0.00223	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SHH—brain cancer	0.000357	0.00223	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TRPC6—brain cancer	0.000351	0.0022	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—ABR—brain cancer	0.00035	0.00219	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—GFAP—brain cancer	0.000346	0.00216	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—GLI1—brain cancer	0.000346	0.00216	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—ERBB2—brain cancer	0.000345	0.00216	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—PDGFRA—brain cancer	0.00034	0.00213	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—GLI1—brain cancer	0.000337	0.00211	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—VAV1—brain cancer	0.000334	0.00209	CbGpPWpGaD
Vardenafil—PDE6G—Signaling by Wnt—CTNNB1—brain cancer	0.000334	0.00209	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HES5—brain cancer	0.000331	0.00207	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—PIK3CG—brain cancer	0.00033	0.00206	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—PIK3CG—brain cancer	0.00033	0.00206	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—VAV1—brain cancer	0.000328	0.00205	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HEY1—brain cancer	0.000328	0.00205	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SUFU—brain cancer	0.000328	0.00205	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—ERBB2—brain cancer	0.000324	0.00203	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—ERBB2—brain cancer	0.000323	0.00202	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—DLL1—brain cancer	0.000321	0.00201	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—ERBB2—brain cancer	0.000321	0.00201	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—ERBB2—brain cancer	0.000319	0.002	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SUFU—brain cancer	0.000319	0.002	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—ABR—brain cancer	0.000318	0.00199	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—DTX2—brain cancer	0.000316	0.00198	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—GFAP—brain cancer	0.000316	0.00198	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—GFAP—brain cancer	0.000308	0.00193	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—ERBB2—brain cancer	0.0003	0.00188	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—ERBB2—brain cancer	0.0003	0.00188	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HEY1—brain cancer	0.0003	0.00188	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—IRS2—brain cancer	0.000298	0.00187	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—VAV1—brain cancer	0.000298	0.00186	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—ERBB2—brain cancer	0.000298	0.00186	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—ERBB2—brain cancer	0.000295	0.00185	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—DLL1—brain cancer	0.000294	0.00184	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—ERBB2—brain cancer	0.000294	0.00184	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HEY1—brain cancer	0.000292	0.00183	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—DLL1—brain cancer	0.000286	0.00179	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000276	0.00173	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SHH—brain cancer	0.000273	0.00171	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000273	0.00171	CbGpPWpGaD
Vardenafil—PDE6G—Signaling by Wnt—MYC—brain cancer	0.00027	0.00169	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	0.000266	0.00167	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TRPC6—brain cancer	0.000263	0.00165	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VAV1—brain cancer	0.000263	0.00165	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—IL2—brain cancer	0.00026	0.00163	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SMO—brain cancer	0.000259	0.00162	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PTCH1—brain cancer	0.000259	0.00162	CbGpPWpGaD
Vardenafil—PDE6G—Disease—VAV1—brain cancer	0.000258	0.00161	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SHH—brain cancer	0.00025	0.00156	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—STAT3—brain cancer	0.000247	0.00155	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SHH—brain cancer	0.000244	0.00152	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TRPC6—brain cancer	0.000241	0.00151	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTCH2—brain cancer	0.00024	0.0015	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—EGFR—brain cancer	0.000239	0.0015	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SMO—brain cancer	0.000237	0.00148	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PTCH1—brain cancer	0.000237	0.00148	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—VAV1—brain cancer	0.000237	0.00148	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TRPC6—brain cancer	0.000235	0.00147	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—PIK3CG—brain cancer	0.000234	0.00146	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HES5—brain cancer	0.000232	0.00145	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—IL2—brain cancer	0.000232	0.00145	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—IL2—brain cancer	0.000232	0.00145	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PTCH1—brain cancer	0.000231	0.00145	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SMO—brain cancer	0.000231	0.00145	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—STAT3—brain cancer	0.000229	0.00143	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—STRADA—brain cancer	0.000225	0.00141	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—EGFR—brain cancer	0.000225	0.00141	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—STAT3—brain cancer	0.000224	0.0014	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—EGFR—brain cancer	0.000224	0.0014	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IDH1—brain cancer	0.000223	0.0014	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—EGFR—brain cancer	0.000222	0.00139	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—TRPC6—brain cancer	0.000222	0.00139	CbGpPWpGaD
Vardenafil—PDE6G—Disease—HES1—brain cancer	0.000222	0.00139	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—EGFR—brain cancer	0.000221	0.00139	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—VEGFA—brain cancer	0.000221	0.00138	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—PIK3CG—brain cancer	0.000212	0.00133	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HEY1—brain cancer	0.000211	0.00132	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PDGFRA—brain cancer	0.000211	0.00132	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—SHH—brain cancer	0.000209	0.00131	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—EGFR—brain cancer	0.000208	0.0013	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—EGFR—brain cancer	0.000208	0.0013	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—PIK3CG—brain cancer	0.000208	0.0013	CbGpPWpGaD
Vardenafil—PDE1B—Disease—DLL1—brain cancer	0.000207	0.0013	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NOTCH2—brain cancer	0.000207	0.0013	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—EGFR—brain cancer	0.000206	0.00129	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—RELA—brain cancer	0.000206	0.00129	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—ERBB2—brain cancer	0.000205	0.00128	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—EGFR—brain cancer	0.000205	0.00128	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—EGFR—brain cancer	0.000204	0.00128	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	0.000203	0.00127	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—TRPC6—brain cancer	0.000201	0.00126	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PTCH1—brain cancer	0.000198	0.00124	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—SMO—brain cancer	0.000198	0.00124	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VAV1—brain cancer	0.000197	0.00124	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—VEGFA—brain cancer	0.000197	0.00123	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—VEGFA—brain cancer	0.000197	0.00123	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—PDGFRA—brain cancer	0.000194	0.00121	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NOTCH2—brain cancer	0.000189	0.00119	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—PIK3CG—brain cancer	0.000189	0.00118	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ABR—brain cancer	0.000188	0.00118	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IRS2—brain cancer	0.000185	0.00116	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NOTCH2—brain cancer	0.000185	0.00116	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	0.000184	0.00116	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GLI2—brain cancer	0.000182	0.00114	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—SKP2—brain cancer	0.000181	0.00113	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VAV1—brain cancer	0.000181	0.00113	CbGpPWpGaD
Vardenafil—PDE1B—Disease—ENO2—brain cancer	0.000176	0.0011	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SHH—brain cancer	0.000176	0.0011	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VAV1—brain cancer	0.000176	0.0011	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GLI1—brain cancer	0.000171	0.00107	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IRS2—brain cancer	0.00017	0.00107	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HES1—brain cancer	0.00017	0.00106	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—TP53—brain cancer	0.000167	0.00105	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—PIK3CG—brain cancer	0.000167	0.00105	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—VAV1—brain cancer	0.000166	0.00104	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—IL2—brain cancer	0.000164	0.00103	CbGpPWpGaD
Vardenafil—PDE6G—Disease—APC—brain cancer	0.000164	0.00103	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SUFU—brain cancer	0.000162	0.00101	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PDGFRA—brain cancer	0.000162	0.00101	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SPP1—brain cancer	0.000157	0.000983	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GFAP—brain cancer	0.000156	0.000978	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—STAT3—brain cancer	0.000156	0.000977	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HES1—brain cancer	0.000155	0.000972	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HES1—brain cancer	0.000151	0.000948	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—VAV1—brain cancer	0.000151	0.000945	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL2—brain cancer	0.000149	0.000935	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TP53—brain cancer	0.000149	0.000932	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TP53—brain cancer	0.000149	0.000932	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HEY1—brain cancer	0.000148	0.000927	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PDGFRA—brain cancer	0.000148	0.000926	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—IL2—brain cancer	0.000147	0.000918	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—DLL1—brain cancer	0.000145	0.000909	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PDGFRA—brain cancer	0.000144	0.000902	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SPP1—brain cancer	0.000144	0.000899	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IRS2—brain cancer	0.000142	0.000889	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—EGFR—brain cancer	0.000142	0.000888	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SPP1—brain cancer	0.00014	0.000876	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—VAV1—brain cancer	0.000138	0.000864	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL2—brain cancer	0.000133	0.000833	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IRS2—brain cancer	0.00013	0.000813	CbGpPWpGaD
Vardenafil—PDE1B—Disease—VAV1—brain cancer	0.000127	0.000797	CbGpPWpGaD
Vardenafil—PDE6G—Disease—ERBB2—brain cancer	0.000127	0.000796	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IRS2—brain cancer	0.000126	0.000792	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—APC—brain cancer	0.000125	0.000785	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PIK3CG—brain cancer	0.000125	0.000785	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SHH—brain cancer	0.000123	0.000773	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TRPC6—brain cancer	0.000119	0.000745	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—IL2—brain cancer	0.000118	0.000736	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—RELA—brain cancer	0.000117	0.000736	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTCH1—brain cancer	0.000117	0.000733	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SMO—brain cancer	0.000117	0.000733	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—ERBB2—brain cancer	0.000117	0.000731	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CG—brain cancer	0.000115	0.000718	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—APC—brain cancer	0.000115	0.000718	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—EGFR—brain cancer	0.000114	0.000715	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PDGFRA—brain cancer	0.000113	0.000707	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—APC—brain cancer	0.000112	0.0007	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CG—brain cancer	0.000112	0.0007	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CTNNB1—brain cancer	0.000111	0.000696	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HES1—brain cancer	0.00011	0.000686	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CG—brain cancer	0.000106	0.000661	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PDGFRA—brain cancer	0.000104	0.000653	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CTNNB1—brain cancer	0.000102	0.00064	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—EGFR—brain cancer	0.000102	0.000637	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP2C9—brain cancer	0.000102	0.000637	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VEGFA—brain cancer	9.99e-05	0.000625	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IRS2—brain cancer	9.92e-05	0.000621	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—RELA—brain cancer	9.79e-05	0.000613	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ERBB2—brain cancer	9.73e-05	0.000609	CbGpPWpGaD
Vardenafil—PDE6G—Disease—STAT3—brain cancer	9.69e-05	0.000607	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CG—brain cancer	9.58e-05	0.0006	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOTCH2—brain cancer	9.35e-05	0.000586	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IRS2—brain cancer	9.15e-05	0.000573	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MYC—brain cancer	9.01e-05	0.000564	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—RELA—brain cancer	8.96e-05	0.000561	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VAV1—brain cancer	8.92e-05	0.000558	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ERBB2—brain cancer	8.9e-05	0.000557	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL2—brain cancer	8.82e-05	0.000552	CbGpPWpGaD
Vardenafil—PDE6G—Disease—EGFR—brain cancer	8.81e-05	0.000552	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—RELA—brain cancer	8.73e-05	0.000547	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ERBB2—brain cancer	8.67e-05	0.000543	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—BSG—brain cancer	8.65e-05	0.000541	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCND1—brain cancer	8.6e-05	0.000538	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CTNNB1—brain cancer	8.51e-05	0.000533	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—EGFR—brain cancer	8.09e-05	0.000507	CbGpPWpGaD
Vardenafil—PDE1B—Disease—APC—brain cancer	8.09e-05	0.000506	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL2—brain cancer	8.07e-05	0.000505	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCND1—brain cancer	7.86e-05	0.000492	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL2—brain cancer	7.86e-05	0.000492	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CTNNB1—brain cancer	7.79e-05	0.000488	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HES1—brain cancer	7.67e-05	0.00048	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCND1—brain cancer	7.66e-05	0.00048	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CTNNB1—brain cancer	7.59e-05	0.000475	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TP53—brain cancer	7.55e-05	0.000473	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—brain cancer	7.5e-05	0.000469	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—IDH1—brain cancer	7.44e-05	0.000466	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—IL2—brain cancer	7.43e-05	0.000465	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—STAT3—brain cancer	7.42e-05	0.000465	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PDGFRA—brain cancer	7.3e-05	0.000457	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SPP1—brain cancer	7.09e-05	0.000444	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MYC—brain cancer	6.9e-05	0.000432	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—brain cancer	6.86e-05	0.000429	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—RELA—brain cancer	6.84e-05	0.000428	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—ERBB2—brain cancer	6.8e-05	0.000426	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—STAT3—brain cancer	6.79e-05	0.000425	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EGFR—brain cancer	6.75e-05	0.000422	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL2—brain cancer	6.74e-05	0.000422	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—brain cancer	6.68e-05	0.000418	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—STAT3—brain cancer	6.62e-05	0.000414	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IRS2—brain cancer	6.41e-05	0.000401	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MYC—brain cancer	6.31e-05	0.000395	CbGpPWpGaD
Vardenafil—PDE1B—Disease—ERBB2—brain cancer	6.28e-05	0.000393	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EGFR—brain cancer	6.17e-05	0.000386	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL2—brain cancer	6.16e-05	0.000386	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MYC—brain cancer	6.15e-05	0.000385	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EGFR—brain cancer	6.01e-05	0.000376	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CTNNB1—brain cancer	5.95e-05	0.000373	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ENO2—brain cancer	5.88e-05	0.000368	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TP53—brain cancer	5.66e-05	0.000355	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CG—brain cancer	5.66e-05	0.000355	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APC—brain cancer	5.66e-05	0.000355	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CTNNB1—brain cancer	5.49e-05	0.000344	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—STAT3—brain cancer	5.19e-05	0.000325	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TP53—brain cancer	5.18e-05	0.000324	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—EGFR—brain cancer	5.16e-05	0.000323	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TP53—brain cancer	5.05e-05	0.000316	CbGpPWpGaD
Vardenafil—PDE1B—Disease—STAT3—brain cancer	4.79e-05	0.0003	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP2C9—brain cancer	4.73e-05	0.000296	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—EGFR—brain cancer	4.71e-05	0.000295	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MYC—brain cancer	4.45e-05	0.000279	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RELA—brain cancer	4.42e-05	0.000277	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ERBB2—brain cancer	4.4e-05	0.000275	CbGpPWpGaD
Vardenafil—PDE1B—Disease—EGFR—brain cancer	4.35e-05	0.000272	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—BSG—brain cancer	4.02e-05	0.000252	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL2—brain cancer	3.98e-05	0.000249	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCND1—brain cancer	3.88e-05	0.000243	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CTNNB1—brain cancer	3.85e-05	0.000241	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—IDH1—brain cancer	3.46e-05	0.000216	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—brain cancer	3.39e-05	0.000212	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—STAT3—brain cancer	3.35e-05	0.00021	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MYC—brain cancer	3.12e-05	0.000195	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EGFR—brain cancer	3.05e-05	0.000191	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ENO2—brain cancer	2.73e-05	0.000171	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CG—brain cancer	2.7e-05	0.000169	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TP53—brain cancer	2.56e-05	0.00016	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CG—brain cancer	1.25e-05	7.85e-05	CbGpPWpGaD
